bovnews13h
Neumora Therapeutics Inc (NMRA) Stock Settles at $2.16: What’s Contributing to This Price Point?
In terms of valuation, Neumora Therapeutics Inc’s market capitalization stands at $348.98 million. Market cap represents the total value of all outstanding shares and is a key indicator of a company’s ...
Neumora Therapeutics, Inc. (NMRA) Investors with Losses are Urged to Contact Levi & Korsinsky to Discuss Their Rights
NEW YORK, NY / ACCESSWIRE / January 23, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Neumora Therapeutics, Inc. ("Neumora Therapeutics, Inc.") (NASDAQ:NMRA) ...
BioSpace2d
J&J’s Spravato Makes Headway in Tough Depression Space With Monotherapy Approval
Esketamine, the active ingredient in Spravato, is a non-selective, non-competitive antagonist of the NMDA receptor, a known ...
Levi & Korsinsky Reminds Shareholders of an Investigation into Neumora Therapeutics, Inc. (NMRA) Regarding Potential Securities Fraud Allegations
NEW YORK, NY / ACCESS Newswire / January 22, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Neumora ...
bovnews4d
Neumora Therapeutics Inc (NMRA) Posted – Profit Margin Last Year—Can It Hold Up?
Neumora Therapeutics Inc’s profitability metrics reveal financial health. The company currently boasts a gross margin of -81.35%. The profit margin, also known as the revenue ratio or gross profit ...
Neumora Therapeutics, Inc. Investigation Ongoing: Contact Levi & Korsinsky About Potential Securities Fraud Allegations - NMRA
NEW YORK CITY, NY / ACCESS Newswire / January 20, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of ...